NOV (NOV) Form 3 NOV / Christy Lynn Novak ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Novak Christy Lynn

(Last) (First) (Middle)

C/O NOV INC.

7909 PARKWOOD CIRCLE DRIVE

(Street)

HOUSTON TX 77036

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2021

3. Issuer Name and Ticker or Trading Symbol
NOV Inc. [ NOV ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
VP, Corp. Controller, CAO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,708	D
Common Stock	1,665(1)	D
Common Stock	4,560(2)	D
Common Stock	9,225(3)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	(4)	02/22/2022	Common Stock	2,490	77.99	D
Non-Qualified Stock Option (right to buy)	(5)	02/16/2023	Common Stock	2,750	63.93	D
Non-Qualified Stock Option (right to buy)	(6)	02/26/2024	Common Stock	4,813	69	D
Non-Qualified Stock Option (right to buy)	(7)	02/26/2025	Common Stock	11,900	54.74	D
Non-Qualified Stock Option (right to buy)	(8)	02/23/2027	Common Stock	6,360	38.86	D
Non-Qualified Stock Option (right to buy)	(9)	02/25/2026	Common Stock	17,940	34.32	D
Non-Qualified Stock Option (right to buy)	(10)	02/29/2028	Common Stock	7,114	35.09	D
Non-Qualified Stock Option (right to buy)	(11)	02/28/2029	Common Stock	6,758	28.72	D
Non-Qualified Stock Option (right to buy)	(12)	02/26/2030	Common Stock	7,912	20.23	D
Non-Qualified Stock Option (right to buy)	(13)	02/23/2031	Common Stock	8,106	15	D

Explanation of Responses:

1. Represents the remaining unvested portion of time-based restricted stock granted on 02/27/2019 pursuant to the Issuer's 2018 Long-Term Incentive Plan, which began vesting in three equal annual installments on the first anniversary of the date of the grant.

2. Represents the remaining unvested portion of time-based restricted stock granted on 02/25/2020 pursuant to the Issuer's 2018 Long-Term Incentive Plan, which began vesting in three equal annual installments on the first anniversary of the date of the grant.

3. Represents a time-based restricted stock award granted on 02/22/2021 pursuant to the Issuer's 2018 Long-Term Incentive Plan, which will vest in three equal annual installments commencing on the first anniversary of the date of the grant.

4. This option is exercisable in three equal annual installments beginning on 02/21/2013.

5. This option is exercisable in three equal annual installments beginning on 02/15/2014.

6. This option is exercisable in three equal annual installments beginning on 02/25/2015.

7. This option is exercisable in three equal annual installments beginning on 02/25/2016.

8. This option is exercisable in three equal annual installments beginning on 02/22/2018.

9. This option is exercisable in three equal annual installments beginning on 02/24/2017 for the first installment, 12/20/2017 for the second installment and 02/24/2019 for the third installment.

10. This option is exercisable in three equal annual installments beginning on 02/28/2019.

11. This option is exercisable in three equal annual installments beginning on 02/27/2020.

12. This option is exercisable in three equal annual installments beginning on 02/25/2021.

13. This option is exercisable in three equal annual installments beginning on 02/22/2022.

Remarks:

See Exhibit 24.1 - Power of Attorney

	/s/ Brigitte Hunt, Attorney-in-Fact For: Christy L. Novak	11/08/2021
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.